The Oncosearch | Oncotarget

Correction: Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells Correction

Jacinth Rajendra, Keshava K. Datta, Sheikh Burhan Ud Din Farooqee, Rahul Thorat, Kiran Kumar, Nilesh Gardi, Ekjot Kaur, Jyothi Nair, Sameer Salunkhe, Ketaki Patkar, Sanket Desai, Jayant Sastri Goda, Aliasgar Moiyadi, Amit Dutt, Prasanna Venkatraman, Harsha Gowda, Shilpee Dutt

Published Nov 6, 2025 · Vol. 16, No. 1 · pp. 791-792

Treatment of glioblastoma with tumor-specific amplitude-modulated radiofrequency electromagnetic fields Research Paper

Hugo Jimenez, Denise Gibo, Sambad Sharma, Michael Pennison, Lance D. Miller, Minghui Wang, Kimberly Sheffield, Liyue Zhang, Allan Johansen, Preeya Achari, Callum Mcgrath, Sean Lester, Jason Tang, Kojo Agyemang, Annette Johnson, Christopher T. Whitlow, Michael Chan, Kounosuke Watabe, Ralph D’Agostino Jr., Janaka Liyanage, Asfar Azmi, Geoffrey Barger, Alexandre Barbault, Glenn J. Lesser, Waldemar Debinski, Boris C. Pasche

Published Oct 2, 2025 · Vol. 16, No. 1 · pp. 741-757

Keywords: amplitude-modulated radiofrequency electromagnetic fields, glioblastoma, TheraBionic, CACNA1H, Ca_v3.2

Beyond DNA damage response: Immunomodulatory attributes of CHEK2 in solid tumors Review

Helen Qian, Heba Ali, Vivekanudeep Karri, Justin T. Low, David M. Ashley, Amy B. Heimberger, Lucy A. Godley, Adam M. Sonabend, Crismita Dmello

Published Jun 5, 2025 · Vol. 16, No. 1 · pp. 445-453

Keywords: CHEK2, immune checkpoint inhibitors, immunomodulation

Durable complete response in leptomeningeal disease of EGFR mutated non-small cell lung cancer to amivantamab, an EGFR-MET receptor bispecific antibody, after progressing on osimertinib Research Paper

Jinah Kim, Liam Il-Young Chung, Horyun Choi, Yoonhee Choi, Maria Jose Aguilera Chuchuca, Youjin Oh, Young Kwang Chae

Published May 21, 2025 · Vol. 16, No. 1 · pp. 411-418

Keywords: amivantamab, monotherapy, rare EGFR mutation, NSCLC, leptomeningeal disease

Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMT Research Paper

Lanlan Zhou, Leiqing Zhang, Jun Zhang, Laura Jinxuan Wu, Shengliang Zhang, Andrew George, Marina Hahn, Howard P. Safran, Clark C. Chen, Attila A. Seyhan, Eric T. Wong, Wafik S. El-Deiry

Published Mar 20, 2025 · Vol. 16, No. 1 · pp. 230-248

Keywords: glioblastoma multiforme, IDH, ONC201, ONC206, MGMT, temozolomide, radiotherapy

Effect of TIMPs and their minimally engineered variants in blocking invasion and migration of brain cancer cells Research Paper

Elham Taheri, Maryam Raeeszadeh-Sarmazdeh

Published Feb 6, 2025 · Vol. 16, No. 1 · pp. 118-130

Keywords: TIMP minimal variants, glioblastoma multiforme (GBM), brain cancer, MMP inhibitors

Retraction: Hyperglycemia via activation of thromboxane A2 receptor impairs the integrity and function of blood-brain barrier in microvascular endothelial cells Retraction

Zhihong Zhao, Jue Hu, Xiaoping Gao, Hui Liang, Haiya Yu, Suosi Liu, Zhan Liu

Published Nov 22, 2024 · Vol. 15, No. 1 · pp. 806-806

Zika virus and brain cancer: Can Zika be an effective treatment for brain cancer? A systematic review Review

Mateus Gonçalves de Sena Barbosa, Beatriz Rodrigues Messias, Rafael Trindade Tatit, Maycon Cristian Gomes de Paula, Valdecir Boeno Spenazato Júnior, Maria Gabriella Borges Braga, Caio Vinícius Marcolino Santos, Luiza D'Ottaviano Cobos, Vinícius Otávio da Silva, Eberval Gadelha Figueiredo, Nicollas Nunes Rabelo, Bipin Chaurasia

Published Aug 28, 2024 · Vol. 15, No. 1 · pp. 662-673

Keywords: Zika, neurotropism, glioblastoma, glioma, brain tumor

Leveraging gold nanostars for precision laser interstitial thermal therapy Editorial

Aden P. Haskell-Mendoza, Ethan S. Srinivasan, Tuan Vo-Dinh, Peter E. Fecci

Published Jun 6, 2024 · Vol. 15, No. 1 · pp. 389-391

Keywords: laser interstitial thermal therapy, gold nanostars, brain tumors, thermal ablation, immunotherapy

BCAS1 defines a heterogeneous cell population in diffuse gliomas Research Paper

Raquel Morales-Gallel, María José Ulloa-Navas, Patricia García-Tárraga, Ricardo Prat-Acín, Gaspar Reynés, Pedro Pérez-Borredá, Luis Rubio, Vivian Capilla-González, Jaime Ferrer-Lozano, José Manuel García-Verdugo

Published Jan 10, 2024 · Vol. 15, No. 1 · pp. 49-64

Keywords: brain tumor, diffuse glioma, oligodendroglioma, glioblastoma, BCAS1

ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines Research Paper

Mathew Lozinski, Nikola A. Bowden, Moira C. Graves, Michael Fay, Bryan W. Day, Brett W. Stringer, Paul A. Tooney

Published Jan 5, 2024 · Vol. 15, No. 1 · pp. 1-18

Keywords: glioblastoma, DNA damage response, ataxia-telangiectasia and rad3-related protein, radiation therapy, temozolomide

Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report Research Paper

Shreya Bhatia, Manuel G. Cortez, Spencer Lessans, Wade T. Iams

Published Jan 5, 2024 · Vol. 15, No. 1 · pp. 27-30

Keywords: EGFR mutation, leptomeningeal disease, non-small cell lung cancer, osimertinib

Combining causal and correlative approaches to discover biomarkers of response to paclitaxel Research Perspective

Alberto Moscona-Nissan, Karl J. Habashy, Victor A. Arrieta, Adam M. Sonabend, Crismita Dmello

Published Jan 2, 2024 · Vol. 15, No. 1 · pp. 117-122

Keywords: glioblastoma, predictive biomarker, CRISPR screen, paclitaxel

UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology Review

Meghan J. Price, Annee D. Nguyen, Jovita K. Byemerwa, Jasmine Flowers, César D. Baëta, C. Rory Goodwin

Published Sep 19, 2023 · Vol. 14, No. 1 · pp. 843-857

Keywords: UDP-6 glucose dehydrogenase, UGDH, cancer, oncology, cancer biology

Systemic treatment for brain metastasis in HER2- positive advanced breast cancer: what have we learned so far? Editorial

Marta Vaz Batista, José Perez-Gracia, Inês Eiriz, Maria Gion, Antonio Llombart, Sofia Braga, Javier Cortés

Published May 12, 2023 · Vol. 14, No. 1 · pp. 701-702

Keywords: brain metastasis, HER2+ breast cancer

Targeting H3K27me3 loss in pediatric brain tumors - a perspective on epigenetically guided cancer therapy Editorial

Michael Goldstein

Published May 5, 2023 · Vol. 14, No. 1 · pp. 444-447

Keywords: epigenetics, brain tumor, EZH2, H3K27me3, radiation therapy

From the groin to the brain: a transfemoral path to blood-brain barrier opening Editorial

Thomas C. Chen, Weijun Wang, Axel H. Schönthal

Published Apr 18, 2023 · Vol. 14, No. 1 · pp. 413-416

Keywords: brain metastases, glioma, NEO100, perillyl alcohol, transfemoral cannulation

Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior Research Paper

Fang Cheng, Victor Chérouvrier Hansson, Grigorios Georgolopoulos, Katrin Mani

Published Mar 13, 2023 · Vol. 14, No. 1 · pp. 219-235

Keywords: Glypican-1, TCGA, bladder carcinoma, hepatocellular carcinoma, glioma

Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells Review

Mikhail V. Blagosklonny

Published Mar 3, 2023 · Vol. 14, No. 1 · pp. 193-206

Keywords: oncology, resistance, cyclotherapy, trilaciclib, rapamycin

Intraventricular immunovirotherapy; a translational step forward Research Perspective

Joshua D. Bernstock, Sarah Blitz, Kyung-Don Kang, Gregory K. Friedman

Published Dec 30, 2022 · Vol. 14, No. 1 · pp. 40-43

Keywords: oncolytic virotherapy, herpes simplex virus (HSV), G207, intraventricular therapy, leptomeningeal disease

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Correction: Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells Correction

Treatment of glioblastoma with tumor-specific amplitude-modulated radiofrequency electromagnetic fields Research Paper

Beyond DNA damage response: Immunomodulatory attributes of CHEK2 in solid tumors Review

Durable complete response in leptomeningeal disease of EGFR mutated non-small cell lung cancer to amivantamab, an EGFR-MET receptor bispecific antibody, after progressing on osimertinib Research Paper

Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMT Research Paper

Effect of TIMPs and their minimally engineered variants in blocking invasion and migration of brain cancer cells Research Paper

Retraction: Hyperglycemia via activation of thromboxane A2 receptor impairs the integrity and function of blood-brain barrier in microvascular endothelial cells Retraction

Zika virus and brain cancer: Can Zika be an effective treatment for brain cancer? A systematic review Review

Leveraging gold nanostars for precision laser interstitial thermal therapy Editorial

BCAS1 defines a heterogeneous cell population in diffuse gliomas Research Paper

ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines Research Paper

Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report Research Paper

Combining causal and correlative approaches to discover biomarkers of response to paclitaxel Research Perspective

UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology Review

Systemic treatment for brain metastasis in HER2- positive advanced breast cancer: what have we learned so far? Editorial

Targeting H3K27me3 loss in pediatric brain tumors - a perspective on epigenetically guided cancer therapy Editorial

From the groin to the brain: a transfemoral path to blood-brain barrier opening Editorial

Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior Research Paper

Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells Review

Intraventricular immunovirotherapy; a translational step forward Research Perspective

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Correction: Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells Correction

Treatment of glioblastoma with tumor-specific amplitude-modulated radiofrequency electromagnetic fields Research Paper

Beyond DNA damage response: Immunomodulatory attributes of CHEK2 in solid tumors Review

Durable complete response in leptomeningeal disease of EGFR mutated non-small cell lung cancer to amivantamab, an EGFR-MET receptor bispecific antibody, after progressing on osimertinib Research Paper

Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMT Research Paper

Effect of TIMPs and their minimally engineered variants in blocking invasion and migration of brain cancer cells Research Paper

Retraction: Hyperglycemia via activation of thromboxane A2 receptor impairs the integrity and function of blood-brain barrier in microvascular endothelial cells Retraction

Zika virus and brain cancer: Can Zika be an effective treatment for brain cancer? A systematic review Review

Leveraging gold nanostars for precision laser interstitial thermal therapy Editorial

BCAS1 defines a heterogeneous cell population in diffuse gliomas Research Paper

ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines Research Paper

Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report Research Paper

Combining causal and correlative approaches to discover biomarkers of response to paclitaxel Research Perspective

UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology Review

Systemic treatment for brain metastasis in HER2- positive advanced breast cancer: what have we learned so far? Editorial

Targeting H3K27me3 loss in pediatric brain tumors - a perspective on epigenetically guided cancer therapy Editorial

From the groin to the brain: a transfemoral path to blood-brain barrier opening Editorial

Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior Research Paper

Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells Review

Intraventricular immunovirotherapy; a translational step forward Research Perspective